| PSKY |
Report |
Total revenue |
IN-LINE |
pred ~$6.89B vs. cons $6.87B |
MEDIUM |
| PSKY |
Report |
Adjusted EBITDA |
BEAT |
pred ~$0.99B vs. cons $0.95B |
MEDIUM |
| PSKY |
Report |
Paramount+ subscribers |
BEAT |
pred ~79.4M vs. cons 79.0M |
LOW |
| PSKY |
Guide |
FY26 total revenue |
UNCHANGED |
guide ~$30.0B vs. cons $30.0B (FY26) |
HIGH |
| PSKY |
Guide |
FY26 adjusted EBITDA |
UNCHANGED |
guide ~$3.8B vs. cons $3.8B (FY26) |
MEDIUM |
| PSKY |
Guide |
WBD merger closing timing |
LOWER |
guide ~2027-06 vs. cons 2026-09 (transaction closing period) |
HIGH |
| PSKY |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| PSKY |
Return |
5-day cumulative residual |
-1.5% (FADE) |
A modest EBITDA and subscriber beat should initially reward the standalone operating trajectory, but unchanged FY26 revenue and EBITDA targets leave no out-period estimate upside. Confirmation that the WBD closing shifts from roughly 2026-09 toward 2027-06 extends financing, dilution, and integration uncertainty, likely pulling revisions and the residual return lower after the initial move. |
MEDIUM |